Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/29/2009WO2009130506A2 Compounds for use in therapy
10/29/2009WO2009130301A1 Improved treatment of cancer using tlr3 agonists in combination with another therapeutic agent
10/29/2009WO2009130296A2 Anti-alk1 antibodies and uses thereof
10/29/2009WO2009130261A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009WO2009130256A2 Compositions and methods for preventing or treating aids
10/29/2009WO2009129980A1 Method for the prevention and treatment of cancer by inhibition of gpvi
10/29/2009WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009WO2009129561A1 Anti-viral nutraceutical
10/29/2009WO2009109911A8 Methods of treating chronic pain
10/29/2009WO2009109855A3 Immunotherapy for unresectable pancreatic cancer
10/29/2009WO2009108738A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells
10/29/2009WO2009104911A3 Uses as agents for prophylaxis or treatment of cervical cancer
10/29/2009WO2009102909A3 Anti-cancer vaccines
10/29/2009WO2009099991A3 Treatment of cancer
10/29/2009WO2009085025A3 System and method for sparql-query processing using parametrized-sparql-query in dbms-based systems
10/29/2009WO2009082624A3 Antagonists of il-17a, il-17f, and il-23 and methods of using the same
10/29/2009WO2009070243A3 Wise binding antibodies and epitopes
10/29/2009WO2009048538A3 Use of anti-amyloid beta antibody in ocular diseases
10/29/2009WO2009037264A3 Colonic delivery of antimicrobial agents
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270591 Novel surface antigen
10/29/2009US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins
10/29/2009US20090270316 Her-2 binding antagonists
10/29/2009US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269406 Therapeutic uses of biocompatible biogel compositions
10/29/2009US20090269372 Enhanced Antiviral Activity Against Foot and Mouth Disease
10/29/2009US20090269371 Process for the production of monoclonal antibodies
10/29/2009US20090269370 Vaccines comprising multimeric hsp60 peptide carriers
10/29/2009US20090269368 Pseudomonas exotoxin a-like chimeric immunogens
10/29/2009US20090269367 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/29/2009US20090269366 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody
10/29/2009US20090269365 Immunogenic vaccinia peptides and methods of using same
10/29/2009US20090269364 Her-2/neu multi-peptide vaccine
10/29/2009US20090269363 Method for screening peptides for use in immunotherapy
10/29/2009US20090269362 Method for Controlling Immunodominance
10/29/2009US20090269361 Constructs for delivery of therapeutic agents to neuronal cells
10/29/2009US20090269360 Therapy
10/29/2009US20090269359 Method of Treatment and Prophylaxis of Diseases Related to Amyloid Deposition Using IGM
10/29/2009US20090269358 Proteins with Improved Solubility and Methods for Producing and Using Same
10/29/2009US20090269357 ANTI-TNFalpha ANTIBODY
10/29/2009US20090269356 Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
10/29/2009US20090269355 Catalytic antibodies and a method of producing same
10/29/2009US20090269354 Quinazoline derivatives and methods of treatment
10/29/2009US20090269353 Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents
10/29/2009US20090269352 Antitumor agent comprising sulfonamide-containing heterocyclic compound combined with an angiogenesis inhibitor
10/29/2009US20090269351 Method of diagnosing and treating glioma
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269348 Pancreatic Cancer Genes
10/29/2009US20090269347 Pancreatic Cancer Genes
10/29/2009US20090269346 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for LRP2 and Uses Thereof
10/29/2009US20090269345 CLN248 Antibody Compositions and Methods of Use
10/29/2009US20090269344 Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
10/29/2009US20090269343 Dual Specific Immunotoxin for Brain Tumor Therapy
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269341 Lytic domain fusion constructs and methods of making and using same
10/29/2009US20090269340 Antibodies to oncostatin m receptor
10/29/2009US20090269339 Responses to immunizations in rheumatoid arthritis patients treated with a cd20 antibody
10/29/2009US20090269338 Humanized anti-factor d antibodies and uses thereof
10/29/2009US20090269337 Compositions and methods for treating diabetes
10/29/2009US20090269336 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy
10/29/2009US20090269335 Therapeutic agent for prostate cancer
10/29/2009US20090269334 Biomarkers for graft rejection
10/29/2009US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/29/2009US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009US20090269331 Caspase-8 and inflammation, infection and wound healing
10/29/2009US20090269330 Fatty acid triglycerides for making biocompatible coatings
10/29/2009US20090269329 Combination Therapeutic products and systems
10/29/2009US20090269304 Methods of treating cancer using il-21 and monoclonal antibody therapy
10/29/2009US20090269302 Human antibodies that bind human il-12 and methods for producing
10/29/2009US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant
10/29/2009US20090269282 Methods for treating, preventing and diagnosing procine ttv infection
10/29/2009CA2727973A1 Peptidyl diacylglycerides
10/29/2009CA2722240A1 Tat protein for preventing or treating aids
10/29/2009CA2722184A1 Regulatory b cells and their uses
10/29/2009CA2722173A1 Methods of identifying anti-inflammatory compounds
10/29/2009CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus
10/29/2009CA2722018A1 Method for the prevention and treatment of cancer by inhibition of gpvi
10/29/2009CA2721983A1 Anti-tnf (alpha) antibody
10/29/2009CA2721927A1 Auris formulations for treating otic diseases and conditions
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009CA2721833A1 Prion epitopes and methods of use thereof
10/29/2009CA2721800A1 Nanoemulsion influenza vaccine
10/29/2009CA2721716A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009CA2721657A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009CA2720677A1 Compositions and methods to enhance the immune system
10/29/2009CA2720465A1 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/28/2009EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens
10/28/2009EP2112220A2 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
10/28/2009EP2112167A2 Humanized ANTI-ERBB2 antibodies and treatment with ANTI-ERBB2 antibodies
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin
10/28/2009EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/28/2009EP2111870A1 Dosages for treatment of anti-erbB2 antibodies
10/28/2009EP2111869A1 Compositions and methods to enhance the immune system
10/28/2009EP2111234A1 Methods of releasing sporocysts from oocysts using controlled shear forces
10/28/2009EP2111233A2 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
10/28/2009EP2111232A1 A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections
1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 1823